10x Genomics Overview
- Year Founded
-
2012
- Status
-
Public
- Employees
-
2,083
- Stock Symbol
-
TXG
- Investments
-
6
- Share Price
-
$19.84
- (As of Monday Closing)
10x Genomics General Information
Description
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Contact Information
Website
www.10xgenomics.comCorporate Office
- 6230 Stoneridge Mall Road
- Pleasanton, CA 94588-3260
- United States
Corporate Office
- 6230 Stoneridge Mall Road
- Pleasanton, CA 94588-3260
- United States
10x Genomics Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $19.84 | $20.02 | $15.28 - $57.90 | $2.39B | 120M | 1.8M | -$2.02 |
10x Genomics Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 2,048,691 | 6,356,519 | 3,814,891 | 16,119,702 |
| Revenue | 631,733 | 618,727 | 516,409 | 490,490 |
| EBITDA | (206,081) | (222,017) | (135,136) | (24,801) |
| Net Income | (239,784) | (255,099) | (166,000) | (58,223) |
| Total Assets | 929,668 | 965,143 | 1,028,980 | 1,018,826 |
| Total Debt | 89,482 | 95,370 | 95,176 | 81,978 |
10x Genomics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
10x Genomics Comparisons
Industry
Financing
Details
10x Genomics Competitors (13)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NanoString Technologies | Formerly VC-backed | Seattle, WA | ||||
| Standard BioTools | Formerly VC-backed | San Francisco, CA | ||||
| Miltenyi Biotec | Private Debt Financed | Bergisch Gladbach, Germany | ||||
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| Avitide | Formerly VC-backed | Lebanon, NH |
10x Genomics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
News about 10x Genomics
Dive into recent articles by PitchBook offering invaluable insights and context.
10x Genomics Patents
10x Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240287599-A1 | Reference free spot deconvolution in spatial transcriptomics | Pending | 27-Feb-2023 | ||
| US-20240263220-A1 | In situ analysis of variant sequences in biological samples | Pending | 03-Feb-2023 | ||
| US-20240301475-A1 | Methods and compositions for detection using nucleic acid probes | Pending | 03-Feb-2023 | ||
| US-20240264155-A1 | Methods and compositions for in situ analysis using detectably labeled magnetic particles | Pending | 01-Feb-2023 | ||
| US-20240263219-A1 | Methods and compositions for in situ analysis of variant sequences | Pending | 06-Jan-2023 | C12Q1/6841 |
10x Genomics Executive Team (33)
| Name | Title | Board Seat |
|---|---|---|
| Jill Herschleb Ph.D | Senior Director of cell biology | |
| Serge Saxonov Ph.D | Co-founder, Board Member and Chief Executive Officer | |
| Adam Taich | Chief Financial Officer, Finance & Chief Accounting Officer, Accounting | |
| Justin McAnear | Chief Financial Officer, Finance & Chief Accounting Officer, Accounting | |
| Michael Schnall-Levin Ph.D | Founding Scientist & Chief Technology Officer |
10x Genomics Board Members (10)
| Name | Representing | Role | Since |
|---|---|---|---|
| Self | Board Member | ||
| Self | Chairman & Board Member | ||
| Self | Board Member | ||
| Self | Board Member | ||
| Self | Board Member |
10x Genomics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
10x Genomics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
10x Genomics Investments & Acquisitions (6)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Centrillion Technologies (Certain Intangible and Other Assets) | 14-Jul-2023 | Buildings and Property | |||
| Tetramer Shop | 08-Jan-2021 | Biotechnology | |||
| ReadCoor | 13-Oct-2020 | Discovery Tools (Healthcare) | |||
| Cartana | 21-Aug-2020 | Drug Discovery | |||
| Spatial Transcriptomics | 10-Dec-2018 | Merger/Acquisition | Biotechnology |
10x Genomics ESG
Risk Overview
Risk Rating
Updated May, 31, 2024
22.53 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 16,009
Rank
Percentile
Pharmaceuticals
Industry
of 909
Rank
Percentile
Laboratory Equipment and Services
Subindustry
of 59
Rank
Percentile
10x Genomics FAQs
-
When was 10x Genomics founded?
10x Genomics was founded in 2012.
-
Who is the founder of 10x Genomics?
Serge Saxonov Ph.D, Michael Schnall-Levin Ph.D, Benjamin Hindson, and Kevin Ness Ph.D are the founders of 10x Genomics.
-
Who is the CEO of 10x Genomics?
Serge Saxonov Ph.D is the CEO of 10x Genomics.
-
Where is 10x Genomics headquartered?
10x Genomics is headquartered in Pleasanton, CA.
-
What is the size of 10x Genomics?
10x Genomics has 2,083 total employees.
-
What industry is 10x Genomics in?
10x Genomics’s primary industry is Biotechnology.
-
Is 10x Genomics a private or public company?
10x Genomics is a Public company.
-
What is 10x Genomics’s stock symbol?
The ticker symbol for 10x Genomics is TXG.
-
What is the current stock price of 10x Genomics?
As of 07-Oct-2024 the stock price of 10x Genomics is $19.84.
-
What is the current market cap of 10x Genomics?
The current market capitalization of 10x Genomics is $2.39B.
-
What is 10x Genomics’s current revenue?
The trailing twelve month revenue for 10x Genomics is $632M.
-
Who are 10x Genomics’s competitors?
NanoString Technologies, Standard BioTools, Miltenyi Biotec, Illumina, and Avitide are some of the 13 competitors of 10x Genomics.
-
What is 10x Genomics’s annual earnings per share (EPS)?
10x Genomics’s EPS for 12 months was -$2.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
